Evidence map

ReviewNPJ precision oncology2026

Targeted immunotherapies and nanomedicines for ovarian cancer: the way forward.

Yue Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 41535510